These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34555693)

  • 1. A simple pan-specific RNN model for predicting HLA-II binding peptides.
    Heng Y; Kuang Z; Xie W; Lan H; Huang S; Chen L; Shi T; Xu L; Pan X; Mei H
    Mol Immunol; 2021 Nov; 139():177-183. PubMed ID: 34555693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pan-Specific GRU-Based Recurrent Neural Network for Predicting HLA-I-Binding Peptides.
    Heng Y; Kuang Z; Huang S; Chen L; Shi T; Xu L; Mei H
    ACS Omega; 2020 Jul; 5(29):18321-18330. PubMed ID: 32743207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeepSeqPanII: An Interpretable Recurrent Neural Network Model With Attention Mechanism for Peptide-HLA Class II Binding Prediction.
    Liu Z; Jin J; Cui Y; Xiong Z; Nasiri A; Zhao Y; Hu J
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2188-2196. PubMed ID: 33886473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
    Xu Y; Luo C; Qian M; Huang X; Zhu S
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of recurrent neural network in prognosis of peritoneal dialysis].
    Tang W; Gao JY; Ma XY; Zhang CH; Ma LT; Wang YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):602-608. PubMed ID: 31209438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning.
    Wang M; Lei C; Wang J; Li Y; Li M
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38600667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepNetBim: deep learning model for predicting HLA-epitope interactions based on network analysis by harnessing binding and immunogenicity information.
    Yang X; Zhao L; Wei F; Li J
    BMC Bioinformatics; 2021 May; 22(1):231. PubMed ID: 33952199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting HLA class II antigen presentation through integrated deep learning.
    Chen B; Khodadoust MS; Olsson N; Wagar LE; Fast E; Liu CL; Muftuoglu Y; Sworder BJ; Diehn M; Levy R; Davis MM; Elias JE; Altman RB; Alizadeh AA
    Nat Biotechnol; 2019 Nov; 37(11):1332-1343. PubMed ID: 31611695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism.
    Ye Y; Wang J; Xu Y; Wang Y; Pan Y; Song Q; Liu X; Wan J
    BMC Bioinformatics; 2021 Jan; 22(1):7. PubMed ID: 33407098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
    Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
    Front Immunol; 2020; 11():1705. PubMed ID: 32903714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction.
    Nielsen M; Lund O
    BMC Bioinformatics; 2009 Sep; 10():296. PubMed ID: 19765293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
    Shen WJ; Zhang X; Zhang S; Liu C; Cui W
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.